Diagnostics in Life Sciences is the Key to Healthcare w/ Mara Aspinall of Illumina Ventures - AZ TRT S05 EP12 (227) 3-24-2024
Release Date: 03/27/2024
AZ Tech Roundtable 2.0
ARK Invest Big Ideas 2024 Report - AI, Robotics, Sequencing, Energy & Blockchain AZ TRT S05 EP16 (231) 4-21-2024 What We Learned This Week: ARK Invest Big Ideas Report 2024 by Cathie Wood & Team Topics: AI, Robotics, Sequencing, Energy, & Blockchain Impact on technology, economy, & people’s lives Disruptive Innovation will be the driving force in society Topics: AI, Robotics, Sequencing, Energy, & Blockchain From ARK Invest Website: The Big Ideas report is a comprehensive study of disruptive technologies, with more than 160...
info_outline Best of Clean Energy, EVs & Battery Power - AZ TRT S05 EP15 (230) 4-14-2024AZ Tech Roundtable 2.0
Best of Clean Energy, EVs & Battery Power AZ TRT S05 EP15 (230) 4-14-2024 What We Learned This Week Steve Zylstra of AZ Tech Council on Clean Energy Daniel Tonkopiy of Delfast Bikes on EV bikes Praveen of Monarch Tractor on AI, EVs & Farming Mark Hanchett of Atliss Motors on EV Trucks & Batteries Clean Energy - many Tech Co's working on zero emission plan Delfast E Bikes – smart bike, connects to E Bike, range of 220 miles on 1 charge, & speed of 50 mph, can drive on all different terrain Monarch Tractor is AgTech working towards a future...
info_outline Opening Day - Gambling & Charlie Hustle w/ Keith O’Brien + History of the World Series by Tyler Kepler NYT Baseball Writer - AZ TRT S05 EP14 (229) 4-7-2024AZ Tech Roundtable 2.0
Opening Day - Gambling & Charlie Hustle w/ Keith O’Brien + History of the World Series by Tyler Kepler NYT Baseball Writer AZ TRT S05 EP14 (229) 4-7-2024 What We Learned This Week Gambling Scandal parallels of Pete Rose vs Dodger’s Shohei Othani Charlie Hustle the icon - Rise & Fall Business of Baseball - Drafting Players to Analytics & how the Game has evolved History of the World Series - Did Babe Ruth call his shot? Guest: Keith O’Brien Website: Keith is the New York Times best-selling author...
info_outline Big Data, AI, + Psychographics – How Amazon, Google & Other Big Tech Keep You on Their Platform Revisited w/ Manu Aggarwal - AZ TRT S05 EP13 (228) 3-31-2024AZ Tech Roundtable 2.0
Big Data, AI, + Psychographics – How Amazon, Google & Other Big Tech Keep You on Their Platform Revisited w/ Manu Aggarwal - AZ TRT S05 EP13 (228) 3-31-2024 What We Learned This Week: Netflix, FB, Amazon, Microsoft, Apple, Google/YT – Tech co’s track all your data, create your profile and serve you what you like and connect you with others of the same interest and feed more interesting data. AI uses a Recommendation Model – you bought this, so you’ll like this. This model is 100x smarter now than years ago (getting smarter) and goes deep down the data...
info_outline Diagnostics in Life Sciences is the Key to Healthcare w/ Mara Aspinall of Illumina Ventures - AZ TRT S05 EP12 (227) 3-24-2024AZ Tech Roundtable 2.0
Diagnostics in Life Sciences is the Key to Healthcare w/ Mara Aspinall of Illumina Ventures AZ TRT S05 EP12 (227) 3-24-2024 What We Learned This Week Diagnostics is the key to healthcare, identifying medical issues and designing the right treatment for the patient Five Levels of Diagnostics – Screening, Diagnosis, Prognosis, Interacting, & Monitoring Illumina Ventures is a life sciences venture capital firm with 35 companies in their portfolio Their investment companies deal in genomics, cancer testing, telehealth, at home testing &...
info_outline Crossing the Chasm & Tech Adoption Revisited w/ Geoffrey Moore - AZ TRT S05 EP11 (226) 3-17-2024AZ Tech Roundtable 2.0
Crossing the Chasm & Tech Adoption Revisited w/ Geoffrey Moore AZ TRT S05 EP11 (226) 3-17-2024 Things We Learned This Week • Crossing the Chasm book (1990) has become part of the lexicon for Tech Industry knowledge, mass influence on Tech CEOs last 25 years, constant references • Chasm – early market vs. mainstream market • 5 Stages of Adoption – Innovators, Early Adopters, Early Market Pragmatists, Late Majority, Laggards • Win tech...
info_outline Leaders Teach us the Why, Playing Infinite Games & A Bit of Optimism w/ Simon Sinek - AZ TRT S05 EP10 (225) 3-10-2024AZ Tech Roundtable 2.0
Leaders Teach us the Why, Playing Infinite Games & A Bit of Optimism w/ Simon Sinek AZ TRT S05 EP10 (225) 3-10-2024 What We Learned This Week Best Selling Author & Speaker Simon Sinek talks Leadership & creating safe environments New Podcast A Bit of Optimism - inspiring stories Start With the Why - tell people the Why, before the What & How Playing Infinite Games - long term over short term Leaders Eat Last - Empathy, care about employees Guest: Simon Sinek, Best Selling Author & Speaker Simon is an unshakeable...
info_outline SciFi Movies & Edward Zwick Hollywood Director - AZ TRT S05 EP09 (224) 3-3-2024AZ Tech Roundtable 2.0
SciFi Movies & Edward Zwick Hollywood Director AZ TRT S05 EP09 (224) 3-3-2024 What We Learned This Week Ed Zwick Hollywood Director & Producer with 40 years in the industry ILM - Industrial Light & Magic is the premiere special fx company created by George Lucas SciFi Movies predicted the Future – what has become reality? The Internet & Choice – How the Martix movie showed us a new reality of virtual worlds that seem too real AI Man vs Machine – Blade Runner and The Terminator movies give terrifying scenarios of AI run amok Guest: Edward...
info_outline Software Delivered AI w/ Brian Stevens of Neural Magic - AZ TRT S05 EP08 (223) 2-25-2024AZ Tech Roundtable 2.0
Software Delivered AI w/ Brian Stevens of Neural Magic AZ TRT S05 EP08 (223) 2-25-2024 What We Learned This Week Neural Magic Deepsparse software helps B2B Clients incorporate AI into their tech stack Large Language Learning Models of AI can be costly & require massive computing power Their clients now control their AI Model Opensource AI Foundation Models for training AI uses a Recommendation Model Guest: Brian Stevens Chief Executive Officer of Neural Magic Brian Stevens is chief executive officer of Neural Magic. A tech...
info_outline IT Setup & Cybersecurity w/ Luciano Aguayo of Redgear - AZ TRT S05 EP07 (222) 2-18-2024AZ Tech Roundtable 2.0
IT Setup & Cybersecurity w/ Luciano Aguayo of Redgear AZ TRT S05 EP07 (222) 2-18-2024 What We Learned This Week RedGear provides turnkey IT solutions for clients. Outsource IT to shift liability IT often an afterthought, when it should be a major priority - lifestyle of tech in a business Data is lifeblood of a company, need security Cybersecurity is just one part, need to monitor physical location, who has access, email, etc Guest: Luciano Aguayo of Redgear Luciano Aguayo is a Texas native, and an active member and contributor to the Southwest...
info_outlineDiagnostics in Life Sciences is the Key to Healthcare w/ Mara Aspinall of Illumina Ventures
AZ TRT S05 EP12 (227) 3-24-2024
What We Learned This Week
- Diagnostics is the key to healthcare, identifying medical issues and designing the right treatment for the patient
- Five Levels of Diagnostics – Screening, Diagnosis, Prognosis, Interacting, & Monitoring
- Illumina Ventures is a life sciences venture capital firm with 35 companies in their portfolio
- Their investment companies deal in genomics, cancer testing, telehealth, at home testing & more
- Future of Biotech will be impacted by both AI and Nanotech
Guest: Mara G. Aspinall, Partner, Illumina Ventures
https://www.illuminaventures.com/
President and CEO, Health Catalysts Group
Board Member of AZ Bio - https://www.azbio.org/
Mara Aspinall is a healthcare industry leader and pioneer with a commitment to civic involvement.
She is a Partner at Illumina Ventures, an independent, global healthcare venture capital firm focused on genomics and precision health investing including diagnostics and therapeutic products. Aspinall has deep roots in venture investing, having co-founded BlueStone Venture Partners in 2017. BlueStone has a strong portfolio of diagnostic, medical device, and digital health companies in the U.S. Southwest.
Throughout her career, Aspinall has spearheaded initiatives to educate payers and policymakers on genomics and personalized medicine. She publishes the popular Sensitive and Specific: The Testing Newsletter and the annual Diagnostics Year in Review. This commitment to expanding knowledge inspired Aspinall to create and co-found the Biomedical Diagnostics master’s degree program at Arizona State University, the only program dedicated exclusively to diagnostics, genetics, and genomics.
Previously, Aspinall was President and CEO of Ventana Medical Systems, a billion-dollar division of TheRoche Group, (now Roche Tissue Diagnostics), a worldwide leader in the development and commercialization of tissue-based cancer diagnostics, where she led more than two dozen major instrument and assay launches and helped position the company as a global leader in companion diagnostics. Aspinall spent 13 years at Genzyme Corporation, where she served as President of Genzyme Genetics and Genzyme Pharmaceuticals. Aspinall transformed the business from a small, specialized player to one of the top five laboratories in the U.S. while setting the industry standard for quality testing. The business was sold to LabCorp for $1 billion in 2010. Aspinall also served as Founder and CEO of On-Q-ity, a start-up diagnostic company dedicated to circulating tumor cells.
During the pandemic, Aspinall emerged as a national authority on COVID testing, serving as the principal investigator at Arizona State University on grants from The Rockefeller Foundation, creating TestingCommons.com and EvidenceCommons.com – internationally recognized interactive databases on COVID diagnostics and related research and clinical applications.
Aspinall was named Arizona Biosciences Leader of the Year by the Arizona Bioindustry Association and one of “100 Most Inspiring People in Life Sciences” by PharmaVOICE magazine. Aspinall has extensive board experience. She has served on multiple public and private company boards in leadership roles over the last ten years. She is currently Chair of the Board of OraSure (OSUR) and Chair of the Nominating & Governance Committee of Castle Biosciences (CSTL). She also serves on the board of BlueCross BlueShield of Arizona.
She holds an MBA from Harvard Business School, a BA in International Relations from Tufts University, and is certified in Cybersecurity Oversight from Carnegie Mellon/NACD.
Notes:
Seg 1
All of life sciences and biotech is healthcare. Diagnostics is the central organizing portion in healthcare, and consists of testing if needed. There are five (5) levels to diagnostics.
Level One is Screening – where a patient may or may not be sick, check the health status, and also could be regular check ups for something pre-diagnosed.
Level Two is the Diagnosis - where tests are taken and then you see the results of the test.
Level Three is the Prognosis – what symptoms does the patient have, and where you need to go from here, what will happen with these symptoms.
Level Four is a newer part called Interacting - This is where you can do personalized medicine and what’s called theranostics or drug treatment. You combine drugs with the treatment. You have to analyze what type of drug is needed. What someone’s body is like, how they metabolize drugs. What dose central levels are needed. People’s reactions to drugs is not just body size or weight as suggested previously, but could be very much based on the genes.
Level Five also new is called Monitoring - If disease treatment is over how do you monitor over the long term. What test do you take to confirm that there’s been no return of the disease. Examples would be an MRD test which stands for a minimal residue disease.
You also may be doing things like CT scans or x-ray scans in the past, but sometimes these do not detect disease properly. Some cancers could be very small and you need a blood test. People may check in through cycles of a disease treatment also.
Seg 2
Regarding monitoring and Level Five using cancer as an example. People may go through 6 rounds of chemotherapy treatment. The doctor should monitor by round 3 and check is the tumor reduced or how is the chemo working.
Do you want to have benchmarks to see if you’re reaching the health goals and if the medicine is effective. Future treatment might be biopsy of a tumor and testing glass to see what drug may work on it.
Revisiting Level Four in personalized medicine you may see in the future Chino metric analysis. Check the risk level for certain diseases so you can have a preemptive process to prevent potential predisposed diseases. This is level A.
Level B would be when diagnosed with a disease, you check the tumor, mutations and genes checking both the DNA and RNA.
Mara is on the board of AZ Bio (.org). The goal of AZ Bio is bringing educated people about biotech together to affect the state, the universities, and companies. Move research along with the responsibility to patients in the medical field.
Mara is involved in venture capital which is critical, because it funds entrepreneurs in good companies to research and create Biotech product processes and products.
There are other levels of investment, which typically start with friends and angel investing then move on to venture capital, and then private equity for really big rounds.
She was the founder of Blue Stone and they invested in Southwest companies.
In the fall of 2023 she became a partner at Illumina Ventures. They deal with 35 different companies. They’ve invested in all levels, biotech and genomics.
You’re looking for a VC to be specialized and knowledgeable about an industry so they can help the business grow provide it with money and add expertise.
Seg 3
Mara and Illumina Ventures recently put out a report - Diagnostics Year in Review. This report covers how did the industry is doing, what stocks earn money, what IPOs there were, financials, clinical, innovation, and mergers and acquisitions.
How does venture-capital work?
Typically you have individual funds one through five. You raise money from investors and invest in new emerging companies.
Companies may be doing research, drug development, or working other areas of life sciences.
Examples of companies in their portfolio:
Delphi deals in cancer, diagnosis test and early screening for cancer and detection test. Level one screen checking for lung cancer and what early symptoms there are. Biopsy can be dangerous so you need other tests.
Let’s Get Checked - a telehealth online company that brings testing to the patient either at home or in an urgent care or ER. This is faster and easier. Examples of test are Covid test and STD test.
Serimmune human immunity research company
Genome Medical a genetic counseling company, working with patients to discuss what diseases they may be predisposed to, and ways to not pass it to the
Seg 4
Future of Biotech
We saw with the pandemic, the rise of telemedicine with faster online diagnosis.
We will also see in the future that AI changes drug development and reading tests
The creation of better and faster equipment. The rise of nanotech, and early detection of diseases with blood samples - for example, at home blood draw.
Check out the Best of Biotech Show:
Best of Biotech from AZ Bio & Life Sciences to Jellatech
What We Learned This Week:
- AZ Bio mission to improve life sciences, & make AZ a Top 10 Bioscience state
- Aqualung Therapeutics is treating inflammation in the lungs, get people off ventilators & save lives
- Calviri is working on a Vaccine to PREVENT Cancer, currently largest animal clinical trial
- Anuncia Medical has a Re-Flow product to help drain fluid from the brain, treats Hydrocephalus
- Collagen 2.0 – Innovation to Gelatin & gummies
Full Show: HERE
AZ Tech Council Shows:
https://brt-show.libsyn.com/size/5/?search=az+tech+council
*Includes Best of AZ Tech Council show from 2/12/2023
Tech Topic:
https://brt-show.libsyn.com/category/Tech-Startup-VC-Cybersecurity-Energy-Science
Best of Tech: https://brt-show.libsyn.com/size/5/?search=best+of+tech
‘Best Of’ Topic: https://brt-show.libsyn.com/category/Best+of+BRT
Thanks for Listening.
Please Subscribe to the BRT Podcast.
AZ Tech Roundtable 2.0 with Matt Battaglia
The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business.
AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving.
Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more…
AZ TRT Podcast Home Page: http://aztrtshow.com/
‘Best Of’ AZ TRT Podcast: Click Here
Podcast on Google: Click Here
Podcast on Spotify: Click Here
More Info: https://www.economicknight.com/azpodcast/
KFNX Info: https://1100kfnx.com/weekend-featured-shows/
Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.